1 April 2025
Farmak International Finalizes Integration of Symphar, Poland
Farmak International has finalized the full integration of Symphar Sp. z o.o. into its international business structure.
Press
Releases
Here you will find the latest updates and news from Farmak International. Discover important announcements, breakthroughs in research, and developments in our ongoing commitment to advancing healthcare. Stay informed about our milestones as we continue to make a positive impact on global health.
28 March 2025
Farmak International Gains Key UK Authorizations: MIA & WDA(H) Secured
Farmak International UK, (legally represented by Farmak Pharmaceuticals UK Ltd), a subsidiary of Farmak Group, has achieved a significant milestone.
3 March 2025
Farmak International at ECR 2025: Expanding Global Access to Essential Pharmaceutical Solutions in Radiology
Farmak International, a global pharmaceutical company with a strong presence in contrast media, complex generics, and anesthesiology and intensive care products, is proud to participate in ECR 2025.
17 February 2025
Farmak International Successfully Completes Aseptic Process Simulation at Spanish Manufacturing Site
Farmak International has reached a major milestone in the development of its Smart Injectables Production Site near Barcelona, Spain, by successfully completing the first validation of Aseptic Process Simulation (APS).
11 February 2025
Where to Meet Farmak International in 2025: Let’s Talk Business
In 2025, Farmak International will be participating in some of the biggest global pharma and healthcare events, offering the perfect opportunity to connect, exchange ideas, and explore business opportunities.
27 December 2024
Farmak International Secures First Marketing Authorization in China for MRI Contrast Agent
Farmak International is proud to announce a significant milestone: the successful registration of our MRI contrast agent in the People's Republic of China.
19 September 2024
Acquisition of A&S Pharma Holdings Ltd (UK-based)
On 19 September 2024, Farmak Pharmaceuticals UK Ltd, a subsidiary of Farmak International, where it holds a majority share, completed the acquisition of a group of generic pharmaceutical companies.
19 June 2024
Farmak AG announces
its rebranding
Farmak AG are to change branding and appearance to Farmak International. This strategic move marks a significant milestone in our company's evolution and aligns with our long-term vision for growth and global expansion.
27 March 2024
Farmak AG acquires Polish pharmaceutical company Symphar Sp. z o.o.
As of 27 March 2024, Farmak AG has successfully finalized its acquisition of Symphar Sp. z o.o., becoming the sole owner of the Polish pharmaceutical company through a cash transaction.
